Health & Pharm General

Blackmores Limited (ASX:BKL) Shareholder Briefing

🕔5/6/2016 10:18:55 AM

Blackmores Limited (ASX:BKL) Shareholder Briefing including Blackmores' Asia Market Strategy.

Read Full Article

FINANCE VIDEO: Blackmores Ltd (ASX:BKL) CEO Christine Holgate and Paul Keogh Share Insights into the New Acquisition

🕔5/6/2016 8:18:43 AM

Following a strong year to date performance delivering sales and profit growth from all areas of the business, Blackmores Ltd (ASX:BKL) has announced their acquisition of Global Therapeutics, Australia's leading Chinese herbal medicine company.

Read Full Article

Blackmores Limited (ASX:BKL) Analysts Briefing

🕔4/28/2016 7:04:24 PM

Blackmores Limited (ASX:BKL) Third Quarter Financial Results to the Nine months ended 31 March 2016

Read Full Article

Blackmores Limited (ASX:BKL) Delivers Record Profits, Up 145% for First Nine Months with Growth From All Businesses and Regions

🕔4/28/2016 1:17:35 PM

Blackmores Limited (ASX:BKL) announces continued strong growth across all regions and brands with a record net profit after tax of $76 million for the first nine months of the financial year, a 145% increase on the prior corresponding period.

Read Full Article

Regeneus Ltd (ASX:RGS) Appendix 4C - Quarterly

🕔4/28/2016 9:22:33 AM

Regeneus Ltd (ASX:RGS) Achieved better than targeted net operating cash flow for the quarter. Cash outflow for the quarter was $1.44 million. Cash flow is tracking consistently better than the target of $1.70 million per quarter.

Read Full Article

Orion Health (NZE:OHE) Builds Momentum in UK, Signs Contracts in England and Scotland

🕔4/12/2016 9:44:10 AM

Orion Health (NZE:OHE) (ASX:OHE) has today announced it has signed two contracts that will significantly extend its presence in the United Kingdom. It will provide a comprehensive technology solution for two leading hospitals in London, and it will implement an integrated health and social care solution for NHS Fife in east Scotland.

Read Full Article

Medigene AG (FRA:MDG1) Sells Partial Stake in Immunocore

🕔4/5/2016 12:31:07 PM

Medigene AG (FRA:MDG1), a clinical stage immune-oncology company focussing on the development of T cell-based immunotherapies for the treatment of cancer, announces that it has today sold 50% of its' stake in the private biotech company Immunocore Ltd., UK, for approximately 4.9 million GBP (approx. EUR 6.1 million).

Read Full Article